Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Notes Payables (2023 - 2024)

Historic Notes Payables for Biofrontera (BFRIW) over the last 2 years, with Q2 2024 value amounting to $296000.0.

  • Biofrontera's Notes Payables changed N/A to $296000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $296000.0, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2023, which is N/A changed from last year.
  • Biofrontera's Notes Payables amounted to $296000.0 in Q2 2024.
  • Biofrontera's Notes Payables' 5-year high stood at $3.9 million during Q4 2023, with a 5-year trough of $296000.0 in Q2 2024.